Swine and Avian Influenza Outbreaks in Recent Times

  • I. W. Fong
Chapter
First Online:
Part of the Emerging Infectious Diseases of the 21st Century book series (EIDC)

Abstract

Influenza A is a zoonotic virus and wild waterfowls are the main reservoir of avian influenza viruses, which are precursors of human influenza A viruses. Through mutations and gene reassortment, some strains of avian influenza viruses establish stable lineages in poultry species, pigs, horses, and humans. The first zoonotic influenza pandemic of the twenty-first century, the swine H1N1 pandemic of 2009, originated from Mexico, and fortunately the virus was only of modest virulence. However, lessons have been learned on the shortcomings of the global preparedness for influenza pandemic, and this should be considered as a valuable experience for the preparation of the next major outbreak. Of more concern is the emergence of the highly pathogenic avian influenza A [H5N1], ongoing since 1996, and the low pathogenic avian influenza A [H7N9], since 2013, which have crossed the species barrier to humans in China. Risks of a H5N1 pandemic appear to be receding with declining human cases, and the H7N9 influenza virus is now the leading candidate as the next pandemic influenza virus. However, influenza pandemics are unpredictable in their timing, specific strain of virus, and origin. Most experts predict that the next influenza pandemic will arise from Asia, especially China, and will be directly of avian origin. Continued influenza surveillance in animals and humans globally with prompt reporting to the WHO and the World Animal Health Organization with sharing of data promptly between countries is essential. Long-term solutions to prevent cross-species transmission of zoonotic influenza viruses to humans and development of more effective, longer-lasting vaccines against emerging avian influenza viruses are needed. Currently there is no evidence of an impending zoonotic or avian influenza pandemic, and the viruses of interest, H5N1 and H7N9 avian influenza A viruses, have not mutated to allow for easy transmission to humans nor human to human.

Keywords

Swine influenza Reassortment Mixing vessel Waterfowls Highly pathogenic avian influenza Low pathogenic avian influenza 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Treanor JJ (2000) Influenza virus. In: Mandell GL, Bennett JC, Dolin R (eds) Principles and practice of infectious diseases, 5th edn. Churchill Livingstone, Philadelphia, pp 1823–1849Google Scholar
  2. 2.
    Ohwada K, Kitame F, Sugawara K, Nishimura H, Homma M, Nakamura K (1987) Distribution of the antibody to influenza C virus in dogs and pigs in Yamagata Prefecture, Japan. Microbiol Immunol 31:1173–1180PubMedCrossRefGoogle Scholar
  3. 3.
    Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531–569PubMedCrossRefGoogle Scholar
  4. 4.
    Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD (2004) Neuramidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 78:12665–12667PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Ina Y, Gobojori T (1994) Statistical analysis of nucleotide sequences of the hemagglutinin gene of human influenza A viruses. Proc Natl Acad Sci U S A 91:8388–8392PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Cox NJ, Subbarao K (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51:407–421PubMedCrossRefGoogle Scholar
  7. 7.
    Stein RA (2009) Lessons from outbreaks of H1N1 influenza. Ann Intern Med 151:407–408CrossRefGoogle Scholar
  8. 8.
    Fitch WM, Bush RM, Bender CA et al (1997) Long term trends in the evolution of H[3] HA1 human influenza type A. Proc Natl Acad Sci U S A 94:7712–7718PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Ma W, Lager KM, Vincent AL, Jarke BH, Gramer MR, Richt RA (2009) The role of swine in the generation of novel influenza viruses. Zoonoses Publ Hlth 56:326–337CrossRefGoogle Scholar
  10. 10.
    Belshe RB (2005) The origins of pandemic influenza lessons from the 1918 virus. N Engl J Med 353:2209–2111PubMedCrossRefGoogle Scholar
  11. 11.
    Fang R, Jou WM, Huyebroeck D, Devos R, Fiers W (1981) Complete structure of A/duck/Ukraine/63 influenza hemagglutinin gene: animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin. Cell 25:315–323PubMedCrossRefGoogle Scholar
  12. 12.
    Medina RA, Garcia-Sastre A (2011) Influenza A viruses: new research developments. Nat Rev Microbiol 9:590–603PubMedCrossRefGoogle Scholar
  13. 13.
    Shope RE (1931) Swine influenza. Filtration experiments and etiology. J Exp Med 54:375–385Google Scholar
  14. 14.
    Webster RG (2002) The importance of animal influenza for human disease. Vaccine 20(Suppl. 2):S16–S20PubMedCrossRefGoogle Scholar
  15. 15.
    Vincent AL, Ma W, Larger KM, Jarke BH, Richt JA (2008) Swine influenza viruses: a North American perspective. Adv Virus Res 72:127–154PubMedCrossRefGoogle Scholar
  16. 16.
    Chamber TM, Hinshaw VS, Kawaoka Y, Easterday BC, Webster RG (1991) Influenza viral infection of swine in the United States 1988–1989. Arch Virol 116:261–265CrossRefGoogle Scholar
  17. 17.
    Webby RJ, Rossow K, Erickson G, Sims Y, Webster R (2004) Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population. Virus Res 103:67–73PubMedCrossRefGoogle Scholar
  18. 18.
    Karasin AI, Carman SA, Olsen CW (2006) Identification of human H1N2 and human-swine reassortment H1N2 and H1N1 influenza A viruses among pigs in Ontario, Canada [2003–2005]. J Clin Microbiol 44:1123–1126PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Rogers GN, Paulson RS, Daniels RS, Skehel JJ, Wilson IA, Wiley DC (1983) Single amino acid substitution in influenza hemagglutinin change receptor binding specificity. Nature 304:76–78PubMedCrossRefGoogle Scholar
  20. 20.
    Subbarao EK, London W, Murphy BR (1993) A single amino acid in the PB2 gene of influenza virus is a determinant of host range. J Virol 67:1761–1764PubMedPubMedCentralGoogle Scholar
  21. 21.
    Scholtissek C, Burger H, Kistner O, Shortridge KF (1985) The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology 147:287–294PubMedCrossRefGoogle Scholar
  22. 22.
    Ito T, Couceiro JN, Kelm S et al (1998) Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 77:7367–7373Google Scholar
  23. 23.
    Yu G, Zhang GH, Hua RH, Zhang Q, Liu TQ, Liao M, Tong GZ (2007) Isolation and genetic analysis of human origin H1N1 and H3N2 influenza viruses from pigs in China. Biochem Biophys Res Commun 356:91–96PubMedCrossRefGoogle Scholar
  24. 24.
    Kundin WD, Easterday BC (1972) Hong Kong influenza infection in swine: experimental and field observations. Bull World Health Organ 47:489–491PubMedPubMedCentralGoogle Scholar
  25. 25.
    Detjen BM, St. Angelo C, Katze MG, Krucy KM (1987) The three influenza virus polymerase [P] proteins not associated with viral nucleocapsids in the infected cells are in the form of a complex. J Virol 61:16–22PubMedPubMedCentralGoogle Scholar
  26. 26.
    Kawaoka Y, Krauss S, Webster RG (1989) Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 63:4603–4608PubMedPubMedCentralGoogle Scholar
  27. 27.
    Brown IH, Harris PA, Mc Cauley JW, Alexander DJ (1998) Multiple genetic reassortment of avian and human influenza A viruses in European pigs, resulting in emergence of an H1N2 novel genotype. J Gen Virol 79:2947–2955PubMedCrossRefGoogle Scholar
  28. 28.
    Claas EC, Kawaoka Y, de Jong JC, Mausrel N, Webster RG (1994) Infection of children with avian-human reassortment influenza virus from pigs in Europe. Virology 204:453–457PubMedCrossRefGoogle Scholar
  29. 29.
    Gregory V, Lim W, Cameron K et al (2001) Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. J Gen Virol 82:1397–1406PubMedCrossRefGoogle Scholar
  30. 30.
    Peiris JS, Guan Y, Markwell D, Ghose P, Webster RG, Shortridge KF (2001) Cocirculation of avian H9N2 and contemporary ‘human’ H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? J Virol 75:9679–9686PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Yu H, Hua RH, Zhang Q, Liu TQ, Liu HL, Li GX, Tong GZ (2008) Genetic evolution of swine influenza A [H3N2] viruses in China from 1970 to 2006. J Clin Microbiol 46:1067–1075PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Ma W, Vincent AL, Gramer MR et al (2007) Identification of H2N3 influenza A viruses from swine in the United States. Proc Natl Acad Sci U S A 104:20949–20954PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Smith TF, Burgert EO Jr, Dowdle WR, Noble GR, Campbell RJ, Van Scoy RE (1976) Isolation of swine influenza virus from autopsy lung tissue of man. N Engl J Med 294:708–710PubMedCrossRefGoogle Scholar
  34. 34.
    Myers KP, Olsen CW, Gray GC (2007) Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 44:1084–1088PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Fineberg HV (2014) Pandemic preparedness and response lessons from the H1N1 influenza of 2009. N Engl J Med 370:1335–1342PubMedCrossRefGoogle Scholar
  36. 36.
    Dominguez-Cheriot G, Lapinsky SE, Marcias AE et al (2009) Critically ill patients with 2009 influenza A [H1N1] in Mexico. JAMA 302:1880–1887CrossRefGoogle Scholar
  37. 37.
    Simonsen L, Spreeuwenberg P, Lustig R et al (2013) Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study. PLoS Med 10:e1001558PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Hancock K, Veguilla V, Lu X et al (2009) Cross reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361:1945–1952PubMedCrossRefGoogle Scholar
  39. 39.
    Trauer JM, Laurie KL, Mc Donnell J, Kelso A, Markey PG (2011) Differential effects of pandemic [H1N1] 2009 on remote and indigenous groups, Northern Territory, Australia, 2009. Emerg Infect Dis 17:1615–1623PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Howclen KJ, Brockhoff EJ, Caya FD et al (2009) An investigation into human pandemic influenza virus [H1N1] 2009 on an Alberta swine farm. Can Vet J 50:1153–1161Google Scholar
  41. 41.
    World Organization for Animal Health. World Animal Health Information Database [WAHID] Interface. Weekly disease information. [cited2010July14]. http://web.oie.int/wahis/public.php?page=weekly-reort-index&admin=0
  42. 42.
    Vijaykrishna D, Poon LL, Zhu HC et al (2010) Reaasortment of pandemic H1N1/2009 influenza A virus in swine. Science 328:1529PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Moreno A, Di Trani L, Faccini S et al (2011) Novel H1N2 swine influenza reassortment strain in pigs derived from the pandemic H1N1/2009 virus. Vet Microbiol 149:472–477PubMedCrossRefGoogle Scholar
  44. 44.
    Starick E, Lange E, Feneidouni S et al (2011) Reassortment pandemic [H1N1] 2009 influenza A virus discovered from pigs in Germany. J Gen Virol 92:1184–1188PubMedCrossRefGoogle Scholar
  45. 45.
    Ducatez MF, Hause B, Stigger-Rosser E et al (2011) Multiple reassortment between pandemic [H1N1] 2009 and endemic influenza viruses in pigs, United States. Emerg Infect Dis 17:1624–1629PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Garten RJ, Davis CT, Russell CA et al (2009) Antigenic and genetic characteristics of swine origin A [H1N1] influenza viruses circulating in humans. Science 325:197–201PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Bagchi S (2015) India tackles H1N1 influenza outbreak. Lancet 387:e21CrossRefGoogle Scholar
  48. 48.
    Epperson S, Jhung M, Richards S et al (2013) Human infections with influenza A [H3N2] variant virus in the United States, 2011–2012. Clin Infect Dis 57(S1):S4–S11PubMedCrossRefGoogle Scholar
  49. 49.
    Morens DM, Taubenberger JK (2011) Pandemic influenza: certain uncertainties. Rev Med Virol 21:262–284PubMedPubMedCentralGoogle Scholar
  50. 50.
    Capua I, Alexander DJ (2008) Ecology, epidemiology and human health implications of avian influenza viruses: why do we need to share genetic data? Zoonoses Publ Hlth 55:2–15CrossRefGoogle Scholar
  51. 51.
    Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG (2005) Characterization of the 1918 influenza virus polymerase genes. Nature 437:889–893PubMedCrossRefGoogle Scholar
  52. 52.
    Capua I, Alexander DJ (2004) Avian influenza: recent developments. Avian Pathol 33:393–404PubMedCrossRefGoogle Scholar
  53. 53.
    Resperant LA, Kuiken T, Osterhaus AD (2012) Influenza vaccines. From birds to humans. Hum Vaccines Immunother 8:7–16CrossRefGoogle Scholar
  54. 54.
    Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawoaka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56:152–179PubMedPubMedCentralGoogle Scholar
  55. 55.
    Fouchier RA, Schneeberger PM, Rozendaal FW et al (2004) Avian influenza A virus [H7N7] associated with human conjunctivitis and a fatal case of respiratory distress syndrome. Proc Natl Acad Sci U S A 101:1356–1361PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Tweed SA, Skowronski DM, David ST et al (2004) Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 10:2196–2199PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Alexander DJ (2000) A review of avian influenza in different bird species. Vet Microbiol 74:3–13PubMedCrossRefGoogle Scholar
  58. 58.
    Yee KS, Carpenter TE, Farver TB, Cardona CJ (2009) An evaluation of transmission routes for low pathogenicity avian influenza virus among chickens sold in live bird markets. Virology 394:19–27PubMedCrossRefGoogle Scholar
  59. 59.
    Lipatov AS, Kwon YK, Pantin-Jackwood MJ, Swayne DE (2009) Pathogenesis of H5N1 influenza virus infection in mice and ferret models differs according to respiratory tract or digestive system exposure. J Infect Dis 199:717–725PubMedCrossRefGoogle Scholar
  60. 60.
    Resperant LA, van de Bildt MW, van Amerongen G et al (2012) Marked endotheliotropism of highly pathogenic avian influenza virus H5N1 following intestinal inoculation in cats. J Virol 86:1158–1165CrossRefGoogle Scholar
  61. 61.
    Hayden F, Croisier A (2005) Transmission of avian influenza viruses to and between humans. J Infect Dis 192:1311–1314PubMedCrossRefGoogle Scholar
  62. 62.
    Skemons RD, Swayne DE (1990) Replication of a waterfowl origin influenza virus in the kidney and intestine of chickens. Avian Dis 34:277–284CrossRefGoogle Scholar
  63. 63.
    Steinbauer DA (1999) Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1–20CrossRefGoogle Scholar
  64. 64.
    Baigent SJ, Mc Cauley JW (2003) Influenza type A in humans, mammals and birds: determinants of virus virulence, host range and interspecies transmission. BioEssays 25:657–671PubMedCrossRefGoogle Scholar
  65. 65.
    Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y (2006) Avian flu: influenza virus receptors in the human airway. Nature 440:435–436PubMedCrossRefGoogle Scholar
  66. 66.
    Van Riel D, Munster VJ, de Wit E et al (2006) H5N1 virus attachment to lower respiratory tract. Science 312:399PubMedCrossRefGoogle Scholar
  67. 67.
    World Organization for Animal Health. 63 countries report H5N1 avian influenza in domestic poultry/wildlife 2003–2010. [cited2010Mar11]. www.oie.int/eng/info-ev/en-AI-factoids-2.htm
  68. 68.
    Liu J, Xiao H, Lei F et al (2005) Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 309:1206PubMedCrossRefGoogle Scholar
  69. 69.
    Keawcharoen J, van Riel D, van Amerongen G et al (2008) Wild ducks as long–distance vectors of highly pathogenic avian influenza [H5N1]. Emerg Infect Dis 14:600–607PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Keawcharoen J, van den Broek J, Bouma A, Trensin T, Osterhaus AD, Heersterbeck H (2011) Wild birds and increased transmission of highly pathogenic avian influenza [H5N1] among poultry, Thailand. Emerg Infect Dis 17:1016–1022PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    World Health Organization Global Influenza Program Surveillance Network (2005) Evolution of H5N1 avian influenza virus in Asia. Emerg Infect Dis 11:1515–1521CrossRefGoogle Scholar
  72. 72.
    Claas ECJ, Osterhaus AD, van Beck R et al (1998) Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472–477PubMedCrossRefGoogle Scholar
  73. 73.
    World Health Organization. Cumulative number of confirmed cases of avian influenza A [H5N1] reported to WHO, 2003–2013. http://www.who.int/influenza/human_animal_interface/EN_GIP_20130604CumulativeNumberH5N1cases.pdf
  74. 74.
    Gomer MR, Kayed AS, Elabd MA et al (2015) Avian influenza A [H5Ni] and A [H9N2] seroprevalence and risk factors for infection among Egyptians: a prospective, controlled seroepidemiological study. J Infect Dis 211:1399–1407CrossRefGoogle Scholar
  75. 75.
    Chang VC, Chan TF, Wen X et al (2011) Infection of immunocompromised patients by avian H9N2 influenza A virus. J Infect Dis 62:394–399Google Scholar
  76. 76.
    Ostrowsky B, Huang A, Terry W et al (2012) Low pathogenic avian influenza A [H7N2] virus infection in immunocompromised adults, New York, USA, 2003. Emerg Infect Dis 18:1128–1131PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Arzey GG, Kirkland PD, Arzey KE et al (2012) Influenza virus A [H10N7] in chickens and poultry abattoir workers, Australia. Emerg Infect Dis 18:814–816PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Centers for Disease Control, Republic of China [Taiwan]. Laboratory-confirmed case of human infection with avian influenza A [H6N1] virus in Taiwan recovered: Taiwan CDC urges public to take precautions to say healthy. http://www.cddc.gov.tw/english/index.asp [June 2013]
  79. 79.
    Wang Y (2013) The H7N9 influenza virus in China changes since SARS. N Engl J Med 368:2348–2349PubMedCrossRefGoogle Scholar
  80. 80.
    To KKW, Chan JFW, Chen H, Li L, Yuen KY (2013) The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet 13:809–821CrossRefGoogle Scholar
  81. 81.
    Gao R, Cao B, Hu Y et al (2013) Human infection with a novel avian-origin influenza A [H7N9] virus. N Engl J Med 368:1888–1897PubMedCrossRefGoogle Scholar
  82. 82.
    Li Q, Zhou L, Zhou M et al (2014) Epidemiology of human infection with avian influenza [H7N9] virus in China. N Engl J Med 370:520–532PubMedCrossRefGoogle Scholar
  83. 83.
    Butler D (2013) Mapping the H7N9 avian influenza outbreaks. Nature 496:145–146PubMedCrossRefGoogle Scholar
  84. 84.
    Chen Y, Liang W, Yang S et al (2013) Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterization of viral genome. Lancet 381:1916–1925PubMedCrossRefGoogle Scholar
  85. 85.
    Zhou H, Gao R, Zhao B et al (2013) Biological features of novel avian influenza A [H7N9] virus. Nature 499:500–505PubMedCrossRefGoogle Scholar
  86. 86.
    Belser JA, Gustin KM, Pearce MB et al (2013) Pathogenesis and transmission of avian influenza A [H7N9] virus in ferrets and mice. Nature 501:556–560PubMedCrossRefGoogle Scholar
  87. 87.
    World Organization for Animal Health. Update on highly pathogenic avian influenza in animals [type H5 and H7]. www.oie.int./animal-health-in-the-world/update-on-avian-influenza/2015. Accessed 25 May 2015Google Scholar
  88. 88.
    World Health Organization. (2015) Avian influenza weekly update, No. 480. http://www.who.int/influenza/human animal interface/en/
  89. 89.
    Vong S (2014) Some perspectives regarding risk factors for A [H7N9] influenza virus infection in humans. Clin Infect Dis 59:795–797PubMedCrossRefGoogle Scholar
  90. 90.
    World Health Organization (2015) WHO risk assessment of human infections with avian influenza A [H7N9] virus. www.who.int./influenza/human animal interface/influenzah7n9/en/Google Scholar
  91. 91.
    Wang X, Fang S, Lu X et al (2014) Seroprevalence to avian influenza A [H7N9] virus among poultry workers and the general population in Southern China: a longitudinal study. Clin Infect Dis 59:e76–e83PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Guan Y, Chen H, Li K et al (2007) A model to control the epidemic of H5N1 at the source. BMC Infect Dis 7:132PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Leung YH, Lau EH, Zhang LJ, Guan Y, Cowling BJ, Peiris JS (2012) Avian influenza and ban on overnight poultry storage in live poultry markets, Hong Kong. Emerg Infect Dis 18:1339–1341PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Swayne DE (2012) Impact of vaccines and vaccination on global control of avian influenza. Avian Dis 56:818–828PubMedCrossRefGoogle Scholar
  95. 95.
    Swayne DE, Spackman E, Pantin-Jackwood M (2014) Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agriculture interface. EcoHealth 11:94–108PubMedCrossRefGoogle Scholar
  96. 96.
    Hsu SM, Chen TH, Wang CH (2010) Efficacy of avian influenza vaccine in poultry: a meta-analysis. Avian Dis 54:1197–1209PubMedCrossRefGoogle Scholar
  97. 97.
    Rahni J, Hoffman D, Harder TC, Beer M (2015) Vaccines against influenza A viruses in poultry and swine: status and future developments. Vaccine 33:2414–2424CrossRefGoogle Scholar
  98. 98.
    Belshe RB, Frey SE, Graham IL et al (2014) Immunogenicity of avian influenza A/Anhui/01/2005 [H5N1] vaccine with MF59 adjuvant. A randomized clinical trial. JAMA 312:1420–1428PubMedCrossRefGoogle Scholar
  99. 99.
    Mulligan MJ, Bernstein DI, Winokur P et al (2014) Serological responses to an avian influenza A/H7N9 vaccine mixed at the point of use with MF59 adjuvant. A randomized clinical trial. JAMA 312:1409–1419PubMedCrossRefGoogle Scholar
  100. 100.
    Sobhanie M, Matsuoka Y, Jegaskanda S et al (2016) Evaluation of the safety and immunogenicity of a live attenuated influenza vaccine [pLAIV] against influenza [H7N9]. J Infect Dis 213:922–929PubMedCrossRefGoogle Scholar
  101. 101.
    Treanor JJ (2014) Expanding options for confronting pandemic influenza. JAMA 312:1401–1402PubMedCrossRefGoogle Scholar
  102. 102.
    Biggerstaff M, Reed C, Swerdlow DL et al (2015) Estimating the potential effects of a vaccine program against an impending influenza pandemic United States. Clin Infect Dis 60(S1):S20–S29PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Lalezani J, Campion K, Keene O, Silagg C (2001) Zanamavir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials. Arch Intern Med 161:212–217CrossRefGoogle Scholar
  104. 104.
    Nicholson KG, Aoki FY, Osterhaus AD, Neuramidase Inhibitor Flu treatment Investigator Group et al (2000) Efficacy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial. Lancet 283:1016–1024Google Scholar
  105. 105.
    Ag D, Arachi D, Hudgins J, Tsafnat G, Coiera E, Bourgeois FT (2014) Financial conflicts of interest and conclusion about neuramidase inhibitors for influenza. An analysis of systematic reviews. Ann Intern Med 161:513–518CrossRefGoogle Scholar
  106. 106.
    Hsu J, Santesso N, Mustafa R et al (2012) Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med 156:512–524PubMedCrossRefGoogle Scholar
  107. 107.
    Muthuri SG, Myles PR, Venkutesan S, Leonardi-Bee J, Nguyen-Van-Tam JS (2013) Impact of neuramidase inhibitor treatment on outcomes of public health importance during the 2009–2010 influenza A [H1N1] pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 207:553–563PubMedCrossRefGoogle Scholar
  108. 108.
    O’Hagan JJ, Wong KK, Campbell AP et al (2015) Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic. Clin Infect Dis 60(S1):S30–S41PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Update (2007) WHO-confirmed human cases of avian influenza A [H5N1] infection, 25 November 2003–24 November 2006. Wkly Epidemiol Rec 82:41–47Google Scholar
  110. 110.
    Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A [H5N1] Virus (2008) Update on avian influenza A [H5N1] virus infection in humans. N Engl J Med 358:261–273CrossRefGoogle Scholar
  111. 111.
    Yen H-L, Zhou J, Choy K-T et al (2014) The R292 K mutation that confers resistance to neuramidase inhibitors lead to competitive fitness loss of A/Shanghai/1/2013 [H7N9] influenza virus in ferrets. J Infect Dis 210:1900–1908PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Ekiert DC, Wilson IA (2012) Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr Opin Virol 2:134–141PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Furuta Y, Gowen BB, Takahashi K, Shiaraki K, Smee DF, Barnard DL (2013) Favipiravir [T-705], a novel viral RNA polymerase inhibitor. Antivir Res 100:446–454PubMedCrossRefGoogle Scholar
  114. 114.
    Hayden F (2009) Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis 48(Suppl. 1):S3–S13PubMedCrossRefGoogle Scholar
  115. 115.
    Sun S, Zhao G, Liu C et al (2015) Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys. Clin Infect Dis 60:486–495CrossRefGoogle Scholar
  116. 116.
    Jegaskanda S, Vandenberg K, Laurie KL et al (2014) Cross-reactive influenza-specific antibody dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses. J Infect Dis 210:1811–1822PubMedCrossRefGoogle Scholar
  117. 117.
    Fang CF, Ma MJ, Zhan BD et al (2015) Nosocomial transmission of avian influenza A [H7N9] virus in China: epidemiological investigation. BMJ 351:h5765. doi: 10.1136/bmj.h5765 PubMedPubMedCentralCrossRefGoogle Scholar
  118. 118.
    Tharakaraman K, Sasisekharan R (2015) Influenza surveillance: 2014–2015 H1N1 ‘swine’-derived influenza viruses from India. Cell Host Microbe 17:279–282PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • I. W. Fong
    • 1
  1. 1.University of TorontoTorontoCanada

Personalised recommendations